Long-acting growth hormone (LAGH) therapy is changing the game for people with growth hormone deficiency (GHD). It's a big step forward because it means fewer injections and better treatment adherence. In Germany, three LAGH products have hit the market: lonapegsomatropin, somapacitan, and somatrogon. The INSIGHTS-GHT registry is tracking how these are being used in...

A rare genetic condition is shedding light on an unexpected connection to ovarian cancer. This condition, known as activated PI3-kinase-delta syndrome, or APDS, is an inherited immune system disorder. It affects how the body's defense system works, making individuals more susceptible to various types of cancer. Let's dive into this complex issue and see what it means...